Pearls of Wisdom
Preparation is key in preventing delays for obtaining orphan drug designation
Orphan Drug products give patients with rare diseases hope. The Orphan Drug Act, originated in 1983, features incentives for companies to develop drugs to treat a rare disease or condition by giving tax credits on clinical trials, eligibility for seven years of market...
Pearl Pathways’ Pannucci reflects on the Innovation Showcase
I attended the Innovation Showcase yesterday at the Dallara headquarters in Speedway Indiana. Aside from the event itself, we were all surprised to be a part of the breaking news when Governor Mike Pence showed up to deliver a speech to announce a new $1B investment...
Could FDA be made into an independent federal body?
Former FDA commissioners recently gathered at the Aspen Ideas Festival’s Spotlight Health discussing ways to minimize bureaucratic and political red tape. FDA’s science based recommendations of safety and efficacy of food and drugs many times have political pressures...
cGMP clinical grade stem cells
Outsourcing-Pharma.com’s Melissa Fassbender recently posted an article on a talk she had with James M. Anderson, M.D., Ph.D., Deputy Director, NIH Division of Program Coordination, Planning and Strategic Initiatives. This exchange reveals information on clinical grade...
Pearl’s Caldwell completes Goldman Sachs 10,000 Small Businesses & welcomed to alumni group
Pearl Pathways is excited to announce that its President and CEO, Diana Caldwell recently completed an elite entrepreneurship training program in the Babson College Cohort of Goldman Sachs’ 10,000 Small Business program. She is among 137 entrepreneurs who graduated...